Rhinomed Limited

ASX:RNO ISIN:AU000000RNO1

Rhinomed Limited ASX:RNO

Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global

TwitterFollow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring

       

News

Rhinomed Limited (ASX:RNO) Completes A$5.0 Million Capital Raise

🕔11/2/2018 10:19:59 AM 1195

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a nasal delivery technology company has successfully undertaken a placement to institutional and sophisticated domestic and international investors at $0.21 per share. The company sought to raise a minimum of A$3.0 million and up to a maximum of A$5.0m and is pleased to report that demand saw the raise close at $A5.0 million.

Read Full Article

Rhinomed Limited (ASX:RNO) Business Update - FY19 Q1 September Quarterly Report

🕔10/31/2018 10:07:30 AM 930

Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) a leader in nasal delivery technology, today announced its 7th consecutive quarter on quarter of revenue growth. Positive trading conditions saw unaudited recognised revenues increase 30% over FY18 Q4 to $1.14m for FY19 Q1.

Read Full Article

Rhinomed Limited (ASX:RNO) Signs 12-Year Licensing Agreement with America's Largest Medical Cannabis Operator - Columbia Care LLC

🕔10/3/2018 8:30:39 AM 1470

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC, the largest and most experienced provider of cannabis-based products and services in the United States (U.S.).

Read Full Article

Rhinomed Limited (ASX:RNO) and US Based Columbia Care LLC to Develop Nasally Delivered Dose Controlled Cannabis Based Medicines

🕔6/21/2018 11:20:00 AM 2600

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors that it has signed a non-binding term sheet with Columbia Care LLC to license Rhinomed's nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogues and derivatives.

Read Full Article

Rhinomed Ltd (ASX:RNO) Business Update - December Quarter

🕔1/30/2018 8:55:12 AM 3442

Respiratory technology company Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) can report another strong quarter of growth. During the quarter the company shipped and invoiced $602k ($1.2m for the half year) worth of stock to retailers, consumers and distributors. This reflects the strength of the Company's growing global retail distribution base.

Read Full Article

Rhinomed Ltd (ASX:RNO) Completes AUD $3.6 Million Capital Raising

🕔11/29/2017 9:44:28 AM 2586

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a leading sleep and nasal respiratory technology company has successfully undertaken an AUD$3.6 million placement to institutional and sophisticated private investors at $0.15 per share.

Read Full Article

Rhinomed Ltd (ASX:RNO) Investor Presentation October 2017

🕔10/5/2017 10:24:59 AM 2943

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) provides the Company's latest Investor Presentation.

Read Full Article

Rhinomed Ltd (ASX:RNO) Preliminary Final Report

🕔8/28/2017 6:45:01 PM 1608

The Directors of Rhinomed Limited ASX:RNO) provide the following Report in relation to the Group for the year ended 30 June 2017.

Read Full Article

Rhinomed Limited (ASX:RNO) Froome Wins 4th Tour De France Using Turbine

🕔7/25/2017 2:49:05 PM 3217

A yellow nose ring matches the yellow jersey. Chris Froome, having taken his 4th Tour de France title continues to support yellow - in the form of an innovative sports breathing device called Turbine(TM).

Read Full Article

Rhinomed Ltd (ASX:RNO) Major Expansion of Mute USA Retail Footprint

🕔7/17/2017 9:55:16 AM 3360

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF), is pleased to announce that it has been advised that its sleep and breathing technology Mute, has been added to the annual 'large set' planogram produced by the Hamacher Resource Group, Inc.

Read Full Article
###

25,208 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 132) (Last 30 Days: 922) (Since Published: 25208) 

Markets ASX:RNO

Company Data

    Headquarters
  • 97 Green St
    Cremorne
    Vic 3121
    Australia
  • Telephone
  • +61-3-8416-0900 
  • Fax
  • +61-3-8080-0796 
  • Principal Sector
  • Consumers 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.rhinomed.com.au
  • E:
  • mjohnson@rhinomed.com.au

Company Reports

Presentations

Quarterly Report

Social Media